| Literature DB >> 32955571 |
Hillary J Mull1,2, Kelly L Stolzmann1, Marlena H Shin1, Emily Kalver1, Marin L Schweizer3,4, Westyn Branch-Elliman1,5,6.
Abstract
Importance: Health care-associated infections (HAIs) are preventable, harmful, and costly; however, few resources are dedicated to infection surveillance of nonsurgical procedures, particularly cardiovascular implantable electronic device (CIED) procedures. Objective: To develop a method that includes text mining of electronic clinical notes to reliably and efficiently measure HAIs for CIED procedures. Design, Setting, and Participants: In this multicenter, national cohort study using electronic medical record data for patients undergoing CIED procedures in Veterans Health Administration (VA) facilities for fiscal years (FYs) 2016 and 2017, an algorithm to flag cases with a true CIED-related infection based on structured (eg, microbiology orders, vital signs) and free text diagnostic and therapeutic data (eg, procedure notes, discharge summaries, microbiology results) was developed and validated. Procedure data were divided into development and validation data sets. Criterion validity (ie, positive predictive validity [PPV], sensitivity, and specificity) was assessed via criterion-standard manual medical record review. Exposures: CIED procedure. Main Outcomes and Measures: The concordance between medical record review and the study algorithm with respect to the presence or absence of a CIED infection. CIED infection in the algorithm included 90-day mortality, congestive heart failure and nonmetastatic tumor comorbidities, CIED or surgical site infection International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis codes, antibiotic treatment of Staphylococci, a microbiology test of a cardiac specimen, and text documentation of infection in specific clinical notes (eg, cardiology, infectious diseases, inpatient discharge summaries).Entities:
Year: 2020 PMID: 32955571 PMCID: PMC7506515 DOI: 10.1001/jamanetworkopen.2020.12264
Source DB: PubMed Journal: JAMA Netw Open ISSN: 2574-3805
Patient and Procedure Characteristics in FY 2016-2017 Development Sample, Medical Record Review Sample, and Cases With Infection
| Variable | No. (%) | ||
|---|---|---|---|
| Flag rate in FY 2016-2017 development sample (N = 9606) | Medical record reviewed | ||
| Total (n = 381) | Infection (n = 47) | ||
| Medical record review confirmed infection | NA | 47 (12.34) | 47 (100) |
| Died <90 d postprocedure | 260 (2.7) | 30 (7.87) | 7 (14.89) |
| Age, mean (SD), y | 71.98 (10.58) | 72.03 (10.45) | 70.63 (9.50) |
| Race | |||
| White | 7537 (78.46) | 295 (77.43) | 43 (91.49) |
| African American | 1487 (15.48) | 64 (16.8) | 2 (4.26) |
| Race not identified or other | 582 (6.06) | 22 (5.77) | 2 (4.26) |
| Hispanic ethnicity | 520 (5.41) | 25 (6.56) | 3 (6.38) |
| Female | 207 (2.15) | 9 (2.36) | 1 (2.13) |
| Select comorbidities | |||
| Congestive heart failure | 4872 (50.72) | 230 (60.37) | 22 (46.81) |
| Coagulopathy | 548 (5.7) | 38 (9.97) | 8 (17.02) |
| Diabetes | |||
| Without chronic complications | 3870 (40.29) | 187 (49.08) | 23 (48.94) |
| With chronic complications | 2661 (27.7) | 146 (38.32) | 17 (36.17) |
| Obesity | 1991 (20.73) | 102 (26.77) | 10 (21.28) |
| Pulmonary circulation disease | 412 (4.29) | 25 (6.56) | 3 (6.38) |
| Renal failure | 2463 (25.64) | 123 (32.28) | 14 (29.79) |
| Solid tumor without metastasis | 792 (8.24) | 34 (8.92) | 7 (14.89) |
| Billing | |||
| Emergent problem | 1193 (12.42) | 55 (14.44) | 10 (21.28) |
|
| |||
| CIED infection | 362 (3.77) | 110 (28.87) | 37 (78.72) |
| SSI infection only | 53 (0.55) | 11 (2.89) | 4 (8.51) |
| Unspecified infection | 130 (1.35) | 16 (4.2) | 2 (4.26) |
| Vitals | |||
| Body temperature ≥38 °C up to 30 d postprocedure | 260 (2.71) | 42 (11.02) | 7 (14.89) |
| Pharmacy order | |||
| No antibiotic ordered | 7726 (80.43) | 162 (42.52) | 15 (31.91) |
| Any antibiotics or drug class with duration ≥3 consecutive d, ordered between 6-90 d postprocedure | 1880 (19.57) | 219 (57.48) | 32 (68.09) |
| Antibiotic | |||
| Typically used to treat to | 1572 (16.36) | 185 (48.56) | 30 (63.83) |
| Not typically used to treat | 308 (3.21) | 34 (8.92) | 2 (4.26) |
| Laboratory orders | |||
| Blood specimens from bacteriology reports with positive cultures that had antibiotic susceptibility testing performed | 906 (9.43) | 162 (42.52) | 41 (87.23) |
| Cardiac specimens from bacteriology reports with positive cultures that had antibiotic susceptibility testing performed | 160 (1.67) | 48 (12.6) | 21 (44.68) |
| Miscellaneous (eg, wound, abscess) specimens from bacteriology reports with positive cultures that had antibiotic susceptibility testing | 923 (9.61) | 49 (12.86) | 1 (2.13) |
| Laboratory results | |||
| Microbiology order and keyword search of microbiology results found | 56 (0.58) | 17 (4.46) | 7 (14.89) |
| Microbiology order and keyword search of microbiology results found coagulase negative | 43 (0.45) | 15 (3.94) | 4 (8.51) |
| Microbiology order, but keyword search of microbiology results found no evidence of | 1791 (18.64) | 195 (51.18) | 32 (68.09) |
| Clinical note text | |||
| Keyword search for | 750 (7.81) | 226 (59.32) | 45 (95.74) |
| Keyword search for | 357 (3.72) | 81 (21.26) | 10 (21.28) |
Abbreviations: CIED, cardiovascular implantable electronic device; FY, fiscal year; ICD-10-CM, International Statistical Classification of Diseases, Tenth Revision, Clinical Modification; NA, not applicable; SSI, surgical site infections.
P < .05.
Other includes American Indian or Alaska Native, Asian, Native Hawaiian or other Pacific Islander, and multiracial.
Procedure characteristics used as flags in infection detection algorithm.
Detailed lists of antibiotics, ICD-10-CM codes, and text keywords are available in eTable 2 in the Supplement.
P < .001.
P < .01.
CIED Infection Detection Algorithm Logistic Regression Results for Development and Validation
| Variables | OR (95%CI) | |
|---|---|---|
| Development sample | Validation sample | |
| CIED procedures, No. | 381 | 363 |
| Infections, No. | 47 | 107 |
| Procedure outcomes | ||
| Died <90 d postprocedure | 15.24 (2.3-100.84) | 1.87 (0.57-6.17) |
| Comorbidity | ||
| Congestive heart failure | 0.13 (0.04-0.44) | 0.53 (0.25-1.14) |
| Solid tumor without metastasis | 7.05 (1.29-38.58) | 0.48 (0.18-1.27) |
| Billing data | ||
|
| ||
| CIED infection | 31.79 (5.59-180.89) | 14.33 (6.1-33.65) |
| SSI | 7.28 (0.94-56.35) | 11.71 (3.64-37.64) |
| Pharmacy data | ||
| No antibiotics ≥3 d | 1 [Reference] | 1 [Reference] |
| Antibiotics ≥3 d to treat | 3.27 (1.08-9.93) | 3.03 (1.49-6.15) |
| Antibiotics ≥3 d not related to | 0.4 (0.03-4.79) | 4.67 (0.7-31.1) |
| Laboratory data | ||
| Microbiology order—cardiac | 11.08 (2.84-43.14) | 2.33 (1.12-4.83) |
| Text note data | ||
| Infection | ||
| Diagnosis | 28.59 (3.06-267.09) | 14.62 (4.44-48.08) |
| History | 0.04 (0.01-0.22) | 0.03 (0.01-0.09) |
| Model C statistic | 0.964 | 0.915 |
Abbreviations: CIED, cardiovascular implantable electronic device; ICD-10-CM, International Statistical Classification of Diseases, Tenth Revision, Clinical Modification; OR, odds ratio; SSI, surgical site infections.
Distribution of CIED Procedures by Predicted Probability of Infection and Positive Predictive Validity Results
| FY 2016-2017 development cases, No. (%) (N = 9606) | Medical record review of development sample (n = 381) | FY 2016-2017 validation cases, No. (%) (n = 9606) | Medical record review of validation sample (n = 363) | |||||
|---|---|---|---|---|---|---|---|---|
| No. | PPV, % | No. | PPV, % | |||||
| Medical records reviewed | True infections | Medical records reviewed | True infections | |||||
| Probability range | ||||||||
| 0-<1% | 8883 (92.5) | 188 | 1 | 0.5 | 8883 (92.5) | 68 | 2 | 2.9 |
| 1%-<3% | 226 (2.4) | 52 | 2 | 3.8 | 224 (2.3) | 11 | 1 | 9.1 |
| 3%-<10% | 221 (2.3) | 42 | 3 | 7.1 | 200 (2.1) | 52 | 3 | 5.8 |
| 10%-<50% | 176 (1.8) | 60 | 13 | 21.7 | 193 (2) | 126 | 36 | 28.6 |
| 50%-100% | 100 (1) | 39 | 28 | 71.8 | 106 (1.1) | 106 | 65 | 61.3 |
Abbreviations: CIED, cardiac implantable electronic device; FY, fiscal year; PPV, positive predictive validity.
Figure. Surveillance Model Performance in Development and Validation Samples—Receiver Operating Characteristic Curves for Model Fit
Development sample was 381 of 9606 cardiac implantable electronic device cases in fiscal years 2016 to 2017; validation samples 363 of 9606 cardiac implantable electronic device cases in fiscal years 2016 to 2017. AUC indicates area under curve.
Cardiac Implantable Electronic Device Infection Characteristics Based on Medical Record Review of Algorithm Development and Validation Samples From FY 2016-2017
| Characteristic | Medical record review results, No. (%) (N = 154) |
|---|---|
| Type of infection | |
| Pocket infection | 128 (83.1) |
| Endocarditis | 23 (14.9) |
| Cellulitis only | 3 (1.9) |
| History | |
| Infection, present on admission | 13 (8.4) |
| History of infection | 4 (2.6) |
| Time to infection, mean (SD), d | |
| Pocket infection | 34.8 (20.7) |
| Endocarditis | 39.8 (21.66) |
| Cellulitis only | 33.0 (17.5) |
Abbreviation: FY, fiscal year.